在患有严重精神疾病的人群中比较阿里皮普拉的心脏代谢安全性和有效性:一个向试验仿真试验
Alvin Richards-Belle1, Naomi Launders1, Sarah Hardoon1
1Division of Psychiatry, University College London, London, United Kingdom.
PLoS medicine
|January 23, 2025
概括
与其他抗精神病药物相比,阿里皮普拉在严重精神疾病患者中显示了类似的胆固醇水平,但心脏代谢结果更好. 效果是可比的,为药物选择的临床决定提供了信息.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 有限且相互矛盾的证据存在于阿里皮普拉对严重精神疾病的心脏代谢安全性和有效性的比较.
- 这项研究调查了阿里皮普拉是否提供了更好的心脏代谢特征,与奥兰扎平,奎蒂亚平和Risperidone相比具有相似的有效性.
研究的目的:
- 在患有严重精神疾病的成年人中,比较阿里皮普拉与奥兰扎平,奎蒂亚平和瑞斯佩里的心脏代谢安全性和有效性.
- 为了评估总胆固醇,体重,血压,精神病医院住院和死亡率的差异.
主要方法:
- 一个观察性,真实世界的研究,模拟一个使用英国初级保健数据的头对头试验 (临床实践研究数据链接).
- 包括26537名患有严重精神疾病 (双极性障碍,精神分裂症,精神病) 的成年人,他们被处方了一种新的抗精神病药物 (2005-2017年),随访2年.
- 主要结局:1年后的总胆固醇. 二次结局:精神病医院住院,体重,血压,停止治疗,死亡率. 对混因素进行调整后的分析.
主要成果:
- 阿里皮普拉在1年内显示的总胆固醇水平与奥兰扎平,奎蒂亚平和RISPERIDONE相比相似.
- 接受阿里皮普拉的患者在体重和血压方面表现出改善,特别是与奥兰扎相比.
- 用精神病医院住院率来衡量有效性,在所有研究的抗精神病药物中都是可比的.
结论:
- 阿里皮普拉与其他主要抗精神病药物在严重精神疾病中具有类似的总胆固醇概况.
- 阿里皮普拉似乎在体重和血压管理方面具有优势.
- 没有观察到有效性 (精神病医院住院) 的显著差异,支持知情的临床决策.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
01:28Psychosis and Antipsychotic Drugs: Overview
171
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
171
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:24Mania and Antimanic Drugs: Overview
119
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
119
01:23Antidepressant Drugs: MAOIs and Other Agents
185
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
185
01:21Antipsychotic Drugs: Typical and Atypical Agents
151
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
151